Sinibolimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sinibolimab, covering 2025-02-27 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma [Phase 2]